This Week Health
Alex's Lemonade Stand This Week Health
February 13, 2024

23andMe’s Fall From $6 Billion to Nearly $0

WSJ
|
Summary
23andMe, once valued at $6 billion, now risks Nasdaq delisting with valuation down 98%, under $1 stock; CEO Wojcicki's billions lost; staff reduced 25% via layoffs, subsidiary sale; company unprofitable, may exhaust cash by 2025.

Explore Related Content

Get Daily Headlines Straight to Your Inbox.

Subscribe Now
Healthcare Transformation Powered by Community

© Copyright 2024 Health Lyrics All rights reserved